Steris (STE) Research & Development (2018 - 2026)

Steris has reported Research & Development for 9 years, with the latest figure at $28.6 million in Q2 2026.

• On a quarterly basis, Research & Development rose 8.33% year-over-year to $28.6 million in Q2 2026; TTM through Jun 2026 was $115.1 million, a 6.18% increase from a year earlier, with the FY2026 full-year figure at $112.9 million, up 4.93% from the prior year.
• Research & Development was $28.6 million for Q2 2026 at Steris, down from $28.8 million in the prior quarter.
• The five-year high for Research & Development was $29.5 million in Q4 2025, with the low at $23.3 million in Q1 2023.
• Average Research & Development over 5 years is $26.4 million, with a median of $26.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development soared 41.69% in 2022, then declined 6.17% in 2023.
• Over 5 years, Research & Development stood at $25.5 million in 2022, then retreated by 1.02% to $25.3 million in 2023, then climbed by 8.49% to $27.4 million in 2024, then increased by 7.66% to $29.5 million in 2025, then dropped by 3.05% to $28.6 million in 2026.
• The last three Research & Development figures came in at $28.6 million (Q2 2026), $28.8 million (Q1 2026), and $29.5 million (Q4 2025), per Business Quant data.